Mexico has been continuously facing the new challenges related to the growing biotechnology industry. Mexican authorities have recognized that the current regulation does not generate
Accelerated Patent Grant (AGP) agreement between IMPI-USPTO as a new complement for optimizing patent prosecution in Mexico.
Mexican Institute of Industrial Property (IMPI) has been focusing efforts in reducing timeframe for patent prosecution in Mexico, considering available foreign work products, efforts, and
If you are concerned with the granting of sanitary registrations to generic medicaments, this might be of interest to you
This to inform you about recent developments concerning the request and obtention of Sanitary Registrations (SR) -which is the authorization needed in Mexico for a
3D printing, also referred to as additive manufacturing, is a process of creating solid objects from any file (3dprinting.com, n.d.). The main difference between conventional
Mexican Institute of Industrial Property (IMPI) and European Patent Office (EPO) strategic cooperation enhancing patent-prosecution strategies in Mexico in terms of pharmaceutical patents.
Mexico is the leading country in exports of pharmaceutical products in Latin-American. The pharmaceutical sector in Mexico is considered one of the top ten industries